This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Summit on Hematology and Blood Disorders" (Hematology 2026) October 08 -10, 2026 | Tokyo, Japan has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at hematology@magnusconference.com or call + 1 (702) 988 2320.
Leukemia refers to malignancies of the blood cells as a whole. The kind of leukaemia is determined by the type of cancerous blood cell and how rapidly or slowly it grows. Leukemia develops when the DNA of a single bone marrow cell mutates, making it unable to develop and function normally. The type of leukaemia you have, your age and overall health, and if the leukaemia has spread to other organs or tissues all influence your treatment options. The most prevalent cancer in individuals over 55 is leukaemia, but it is also the most common disease in children under the age of 15.
Lymphoma is a type of cancer that affects the lymphatic system, which is a part of the body's germ-fighting mechanism. Lymph nodes (lymph glands), spleen, thymus gland, and bone marrow are all part of the lymphatic system. All of these locations, as well as other organs throughout the body, can be affected by lymphoma. Lymphoma is relatively treatable, and the prognosis varies depending on the type and stage of lymphoma. One or more of the following treatments may be used: Chemotherapy, radiation therapy, proton therapy, targeted therapy, and surgery are some of the treatments available.
Title : Acute intermittent porphyria: A neurological dilemma obscured by ubiquitous gastrointestinal presentation
Mayank Anand Singh, Mimer Medical College, India
Title : Comprehensive symptom management and supportive nursing care in a preterm toddler undergoing HSCT for pyruvate kinase deficiency
Tran Thi Dung, Vinmec International Hospital, Vietnam
Title : Enhancing Thalassemia Gene Carrier Identification in Non-anemic Populations Using AI Erythrocyte Morphology Analysis and Machine Learning
Junxun Li, First Affiliated Hospital, Sun Yat-sen University, China
Title : Predictive Value of Routine Laboratory Tests for Early Death in Pediatric Hemophagocytic Lymphohistiocytosis Patients
Junxun Li, First Affiliated Hospital, Sun Yat-sen University, China
Title : Eltrombopag added to combined immunosuppressive therapy IST in children with acquired severe aplastic anemia accelerates hematologic recovery and should be continued in the second course of IST
Olga Goronkova, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology , Russian Federation
Title : Arsenic Trioxide and Its Applications
Peng Zhang, Chief physician, China